Infective endocarditis is a complex infection that can be life-threatening. These infections also cause anatomical lesions that can be severe. Their management is complex and involves several disciplines: cardiology, bacteriologists, infectious diseases specialists, radiologists, nuclear medicine specialists, cardiac surgeons, neurologists, pharmacologists, etc. The incidence of Enterococcus faecalis endocarditis is increasing due to the aging of the population and the disappearance of rheumatic fever. The adequate management of these infections is complex and relies on the prolonged administration of high-dose antibiotics, classically the combination of amoxicillin and ceftriaxone. In the context of Streptococcal endocarditis, the impact of increasing the Minimum Inhibitory Concentration (MIC) of amoxicillin on patient mortality has been demonstrated but no study has yet examined the impact of increasing the MIC of amoxicillin on the outcome of patients treated for Enterococcus faecalis infective endocarditis.
Study Type
OBSERVATIONAL
Enrollment
281
Hôpital de La Croix Rousse
Lyon, France
Groupe Hospitalier Paris Saint-Joseph
Paris, France
Describe the epidemiology and clinical presentations of patients with Enterococcus faecalis endocarditis
This outcome corresponds to the evaluation of factors associated with mortality in patients with Enterococcus faecalis endocarditis.
Time frame: Month 1
Impact of increasing the minimum inhibitory concentrations of amoxicillin on the outcome of Enterococcus faecalis infective endocarditis
This outcome corresponds to the description of the epidemiology of Enterococcus faecalis endocarditis in France.
Time frame: Month 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.